Skip to main content

Bleeding Disorders

  • Chapter
  • 873 Accesses

Part of the book series: Pediatric Oncology ((PEDIATRICO,volume 22))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aventis Behring (2000). Dosing schedule for the treatment of bleeding episodes in von Willebrand disease. King of Prussia, PA: Aventis Behring.

    Google Scholar 

  • Barnes, C, Rudzki, Z. & Ekert, H. (2000). Induction of immune tolerance and suppression of anaphylaxis in a child with hemophilia B by simple plasmapheresis and antigen exposure. Hemophilia, 6, 693–695.

    Google Scholar 

  • Cordoni, A. (2000). Von Willebrand’s disease: Diagnosis and treatment. The American Journal of Nurse Practitioners, 4, 9–16.

    Google Scholar 

  • Jadhav, M. & Warrier, I. (2002). Anaphylaxis in patients with hemophilia. Seminars in Thrombosis and Hemostasis, 26 205–208.

    Google Scholar 

  • Jansen, M., Schmaldienst, S., Banyai, S., Quehenberger, P., Pabinger, I., Derfier, K., Hori, W., and Knobl, P. (2001). Treatment of coagulation inhibitors with extracorporeal immunoabsorption. British Journal of Haematology, 112 91–97.

    PubMed  Google Scholar 

  • Kavakli, K. (1999). Fibrin glue and clinical impact on haemophilia care. Haemophilia, 5, 392–396.

    PubMed  Google Scholar 

  • Lusher, J. (2002). Conference report: Highlights from the XXV International Congress of the World Federation of Hemophilia. Medscape General Medicine, 4, 14.

    Google Scholar 

  • Panicker, J., Warrier, I., Thomas, R. and Lusher, J. (2003). The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia, 9, 272–278.

    PubMed  Google Scholar 

  • Shapiro, A. (2003). A global view on prophylaxis: possibilities and consequences. Haemophilia, 9,(suppl. 1), 10–18.

    PubMed  Google Scholar 

  • Schneppenheim, R., Budde, U., Krey, S., Drewke, E., Bergman, F., Lechier, E., Oldenbrug, J. and Schwaab, R. (1996). Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thrombosis and Haemostasis, 76, 587–602.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sevier, N.M. (2005). Bleeding Disorders. In: Tomlinson, D., Kline, N.E. (eds) Pediatric Oncology Nursing. Pediatric Oncology, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26784-0_7

Download citation

  • DOI: https://doi.org/10.1007/3-540-26784-0_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40851-2

  • Online ISBN: 978-3-540-26784-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics